Editorial Team & Review Process
Independent ketamine therapy guidance — sourced from peer-reviewed literature, reviewed by credentialed clinicians, and updated on a published cadence.
Our editorial standards
Ketamine Path is a patient-education publisher. We do not operate a clinic, and we do not accept payments from clinics or pharmacies in exchange for editorial coverage. Everything below describes how content is produced and reviewed.
Sourcing
Claims about safety, dosing, drug interactions, and eligibility are sourced from peer-reviewed clinical literature, FDA labeling, and published clinical practice guidelines. We mark uncertainty explicitly when the evidence is preliminary or contested.
Fact-check process
Articles touching clinical decision-making are reviewed by a credentialed consulting clinician (MD psychiatrist, PharmD, or LCSW) appropriate to the subject before publish. Reviewers may flag claims for revision, citation, or removal.
Conflict of interest
Ketamine Path may earn revenue from display advertising and from clearly-labeled provider listings. Editorial decisions — what we cover, how we describe it, and which providers we recommend questions for — are made independently of advertising relationships and are not shown to advertisers in advance.
Review cadence
Articles are re-reviewed at least every 18 months, or sooner when new FDA actions, guideline updates, or significant peer-reviewed evidence appear. Each article displays its last-reviewed date.
Corrections and contact
Spot an error or have a clinical concern about something we have published? Send a note via our contact page. We review correction requests within 5 business days.
Who reviews our content
Three consulting clinician roles cover the topics on Ketamine Path. We use credential-only attribution; named reviewers will be added as advisory relationships are formalized.
Our 5-step review process
Every clinical article moves through these steps before it is published, and re-enters the cycle on a review cadence.
Research
Gather peer-reviewed literature, FDA labeling, and published clinical guidelines. Flag any patient-anecdote sources as such and never substitute them for clinical evidence.
Draft
Editor writes plain-language draft with explicit uncertainty. We say evidence is limited when it is and do not extrapolate beyond the data.
Clinical review
Subject-appropriate consulting clinician (MD, PharmD, or LCSW) reviews the draft. Reviewer may flag claims for revision, citation, or removal.
Publish
Article goes live with last-reviewed date, schema markup, sourcing footnote, and explicit medical disclaimers.
Re-review
Article re-enters the review cycle at least every 18 months, or sooner when new FDA actions or major guideline updates appear.
Editorial team FAQ
Our consulting reviewers serve in an advisory capacity rather than as employees. Until we formalize each relationship and confirm public disclosure preferences, we use credential-only attribution. We would rather under-claim than risk overstating an individual reviewer's role. Real names will appear here as advisory relationships are formalized and reviewers consent to public attribution.
Articles that touch clinical decision-making — eligibility, dosing, drug interactions, protocols, and safety — are sent to a subject-appropriate consulting reviewer before publish. Pure access, cost, or logistics articles may be edited internally without clinical review when no clinical claims are involved.
Use the contact page to send the article URL, the specific passage in question, and a citation if you have one. We review correction requests within 5 business days and post substantive corrections with a dated note at the bottom of the affected article.
No. Everything on Ketamine Path is patient education based on published clinical literature. It is not a substitute for individualized medical advice. Treatment decisions should be made with a licensed clinician who can evaluate your specific medical history.
Editorial decisions — what we cover, how we describe it, and which provider questions we recommend — are made independently of advertising relationships and are not shown to advertisers in advance. Paid placements (display advertising, sponsored provider listings) are visually distinct and labeled.
Need help or want to reach readers?
Have a correction, provider question, or advertising inquiry? Reach the editorial team.